Evidence mapPaperPMID 42558270Full record

ArticleFrontiers in endocrinology2026

Muscle mass and function in patients with type 2 diabetes mellitus: a characteristic analysis based on sex, age, and BMI.

Ning Lu, Bing-Li Liu, Wen Zhang, Lan-Lan Jiang, Jin-Dan Wu

Abstract read
In one paragraph

Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ning Lu *Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Bing-Li Liu *Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Wen Zhang *Department of Endocrinology, Lishui District People's Hospital of Nanjing, Nanjing, China.
Lan-Lan JiangDepartment of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Jin-Dan WuDepartment of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To investigate the characteristics and determinants of muscle mass and muscle function in patients with type 2 diabetes mellitus (T2DM), stratified by sex, age, and body mass index (BMI). Methods: This is a retrospective cross-sectional study included 838 T2DM patients treated at the Department of Endocrinology and Metabolism, Nanjing First Hospital. Data on body weight, grip strength, gait speed, and other relevant clinical parameters were collected. Regression analyses and subgroup comparisons were performed according to sex, age, and BMI categories to evaluate the features and associated factors of muscle mass and muscle function in T2DM patients. Results: The prevalence of sarcopenia was slightly higher in female T2DM patients than that in males. Binary logistic regression analysis showed that, in addition to advanced age and low BMI, decreased serum albumin (Alb), elevated alkaline phosphatase, and insulin use were also significant risk factors for sarcopenia in male patients with T2DM. Multivariate analysis showed that in males, decreased skeletal muscle index (SMI) was independently associated with older age, low Alb, low creatinine, and low BMI; in females, it was independently associated with older age, low triglycerides, and low BMI. Regarding handgrip strength, older age and higher HbA1c were associated factors in males, whereas older age and longer diabetes duration were associated factors in females. For gait speed, older age and low albumin were associated factors in males, whereas only older age was significant in females. Age-stratified analyses revealed that in males, SMI and handgrip strength remained stable between ages 40 and 60, then declined significantly after 60; in females, declines were observed from approximately age 50. Gait speed decreased after age 70 in both sexes. BMI-stratified analyses revealed that sarcopenia prevalence increases with lower BMI, particularly in males. In males, low handgrip strength and gait speed rose sharply at BMI <18.5; no such association was observed in females. Conclusion: Older age and low BMI are common risk factors associated with sarcopenia in T2DM patients. In males, monitoring of muscle mass and functional decline is warranted after age 60, particularly in the presence of low serum albumin and low BMI. Preventive awareness and measures should be initiated when females reach age 50.

Indexed as

Body Mass IndexDiabetes Mellitus, Type 2Muscle, SkeletalSarcopeniaAgedAge FactorsCross-Sectional StudiesFemaleHand StrengthHumansMaleMiddle AgedPrevalenceRetrospective StudiesRisk FactorsSex Factorsagebody mass indexsarcopeniasextype 2 diabetes mellitus

Identifiers

PMID42558270
PMCPMC13437441

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.